News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioMarker Strategies Names Dr. Samuel Broder to Board of Directors


1/3/2011 9:37:42 AM

BALTIMORE--(BUSINESS WIRE)--BioMarker Strategies announced today that it has appointed three new Directors, including Dr. Samuel Broder, who is a former Director of the National Cancer Institute and Chief Medical Officer at Celera; Dr. Mark Velleca, a founder and former Senior VP of CGI Pharmaceuticals; and, Dr. Paul Beresford, currently the Vice-President of Business Development at Biodesix and former VP of Translational Diagnostics at Ventana Medical Systems.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES